Form 4 Filing for Neermann Joerg

This filing details a Form 4 submission by Neermann Joerg, a director at IMMUNIC, INC. (IMUX). On June 29, 2026, Joerg acquired 25,370 stock options with an exercise price of $10.90 per share. These options were conditionally approved on March 27, 2026, and became fully vested on the same date. The acquisition is subject to stockholder approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, which was obtained at the 2026 Annual Meeting of Stockholders. The options are exercisable until March 27, 2036. Following this transaction, Joerg holds 25,370 shares underlying these options.